User profiles for Jørgen Johansen

Jørgen Johansen

Odense Univesity Hospital
Verified email at dadlnet.dk
Cited by 9355

[HTML][HTML] FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial

LS Mortensen, J Johansen, J Kallehauge… - Radiotherapy and …, 2012 - Elsevier
PURPOSE: Hypoxia is a cause of resistance to radiotherapy, especially in patients with head
and neck squamous cell carcinoma (HNSCC). The purpose of this study was to evaluate …

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial

…, J Bentzen, L Bastholt, O Hansen, J Johansen… - The Lancet, 2003 - thelancet.com
Background Although head and neck cancer can be cured by radiotherapy, the optimum
treatment time for locoregional control is unclear. We aimed to find out whether shortening of …

[BOOK][B] Signs in use: an introduction to semiotics

JD Johansen, SE Larsen - 2005 - api.taylorfrancis.com
Signs in Use is an accessible introduction to the study of semiotics.All organisms, from bees
to computer networks, create signs, communicate, and exchange information. The field of …

Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis

…, V Gregoire, JH Hay, A Hliniak, J Johansen… - The Lancet …, 2017 - thelancet.com
Background The Meta-Analysis of Radiotherapy in squamous cell Carcinomas of Head and
neck (MARCH) showed that altered fractionation radiotherapy is associated with improved …

Prospective study of 18FDG‐PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from …

J Johansen, S Buus, A Loft, S Keiding… - Head & Neck …, 2008 - Wiley Online Library
Background. The benefit of a complementary fluorodeoxyglucose‐positron emission
tomography (FDG‐PET) scan to standard workup for carcinoma of unknown primary (CUP) and …

Single arc volumetric modulated arc therapy of head and neck cancer

A Bertelsen, CR Hansen, J Johansen… - Radiotherapy and …, 2010 - Elsevier
BACKGROUND: The quality of Volumetric Modulated Arc Therapy (VMAT) plans is highly
dependent on the performance of the optimization algorithm used. Recently new algorithms …

Salivary gland carcinoma in Denmark 1990–2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA)

…, MH Therkildsen, J Overgaard, J Johansen… - Oral oncology, 2011 - Elsevier
To describe the incidence, site and histology (WHO 2005) of salivary gland carcinomas in
Denmark. Nine hundred and eighty-three patients diagnosed from 1990 to 2005 were …

The prognostic significance of histological features in oral squamous cell carcinoma

SR Larsen, J Johansen, JA Sørensen… - Journal of oral …, 2009 - Wiley Online Library
Background: Different factors predict nodal metastasis, recurrence and survival in oral cancer.
The aim was to assess the prognostic value of histological features related to the primary …

Turning subjective into objective: the BCCT. core software for evaluation of cosmetic results in breast cancer conservative treatment

…, D Christie, S Costa, F Fitzal, JL Fougo, J Johansen… - The Breast, 2007 - Elsevier
Twelve expert observers from nine different countries convened in a workshop to evaluate
the validity of the Breast Cancer Conservative Treatment. Cosmetic results (BCCT.core) …

The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 …

…, L Specht, E Andersen, J Johansen… - Radiotherapy and …, 2011 - Elsevier
BACKGROUND AND PURPOSE: Tumour HPV-positivity is a favourable prognostic factor in
the radiotherapy of HNSCC, but the optimal radiotherapy regimen for HPV-positive HNSCC …